Investigative Urology - Results from #3920

REVIEW UroToday

Relevance of the mammalian target of rapamycin pathway in the prognosis of patients with high-risk non-muscle invasive bladder cancer - Abstract June 6, 2013

p63-expressing cells are the stem cells of developing prostate, bladder, and colorectal epithelia - Abstract June 6, 2013

Intercellular transfer of P-glycoprotein from the drug-resistant human bladder cancer cell line BIU-87 does not require cell-to-cell contact - Abstract June 6, 2013

Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer - Abstract June 6, 2013

Tetrandrine triggers apoptosis and cell cycle arrest in human renal cell carcinoma cells - Abstract June 6, 2013

Potential biofluid markers and treatment targets for renal cell carcinoma - Abstract June 5, 2013

Suppression of renal cell carcinoma growth in vivo by forced expression of vascular endothelial growth inhibitor - Abstract June 5, 2013

TLR4 mediates MAPK-STAT3 axis activation in bladder epithelial cells - Abstract June 4, 2013

Estrogen receptor-β expression and pharmacological targeting in bladder cancer - Abstract June 4, 2013

GATA3 expression in paragangliomas: A pitfall potentially leading to misdiagnosis of urothelial carcinoma - Abstract June 4, 2013

Current mouse and cell models in prostate cancer research - Abstract June 4, 2013

Overcoming mutation-based resistance to antiandrogens with rational drug design - Abstract June 3, 2013

Circulating MicroRNAs as biomarkers of prostate cancer: The state of play - Abstract June 3, 2013

Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone - Abstract June 3, 2013

Androgen-responsive Serum Response Factor target genes regulate prostate cancer cell migration - Abstract June 3, 2013

FGFR1 is essential for prostate cancer progression and metastasis - Abstract June 3, 2013

Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer - Abstract June 3, 2013

Identification of drug candidate against prostate cancer from the aspect of somatic cell reprogramming - Abstract June 3, 2013

A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy - Abstract May 31, 2013

Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: A report from the DECIDE study group - Abstract May 31, 2013

Page 197 of 346